First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
May 12, 2026
May 12, 2026
HOUSTON, Texas, May 12 -- Rice University posted the following news release:
* * *
First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
*
Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality. Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical . . .
* * *
First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
*
Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality. Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical . . .